Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The BrainDrugs-Epilepsy Study: A Prospective Open-label Cohort Precision Medicine Study in Epilepsy

NCT05450822 is registered in ClinicalTrials.gov with Gitte Moos Knudsen as lead sponsor.

NCT NCT05450822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05450822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The BrainDrugs-Epilepsy Study: A Prospective Open-label Cohort Precision Medicine Study in Epilepsy
Lead sponsor
Gitte Moos Knudsen
Phase
Observational
Overall status
Recruiting
Start date
February 18, 2022
Completion date
December 31, 2031
Enrollment
550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy